We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Nucleonics Receives FDA Clearance to Begin Phase 1 Trial of eiRNA Therapy

News   May 03, 2007

 
Nucleonics Receives FDA Clearance to Begin Phase 1 Trial of eiRNA Therapy
 
 
 

RELATED ARTICLES

Further Calls for Diversity in Genomics Research

News

Broadening diversity among participants in human genomics research will maximize the potential of the field, say members of an international genomics consortium.

READ MORE

Rosalind Franklin Award Recognizes Young Women at the Forefront of Genetics Research

News

The Rosalind Franklin Young Investigator Award honors the phenomenal contributions of Dr. Rosalind Franklin to the field of genetics by providing two young, female geneticists a cash prize of $75,000 to fund their research.

READ MORE

A Way To Extend Survival Rates for Heart Failure?

News

For the first time in preclinical studies, researchers have shown that Aliskiren, a drug that inhibits the enzyme that regulates blood pressure, can delay progression of congestive heart failure and extend survival rates.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE